Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159523523> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W3159523523 endingPage "A352" @default.
- W3159523523 startingPage "A351" @default.
- W3159523523 abstract "Abstract Influenza vaccination (fluv) is free and easily accessible to diabetics in Quebec. The importance of vaccination (v) during the Covid19 (CV19) pandemic has been widely discussed in the media. To ascertain the receptiveness of type 2 diabetics (T2D) to fluv during the CV19 pandemic and their acceptance of an eventual CV19 vaccine (CVv) we carried out telephone interviews with 34 unselected T2D pts in Montreal, Quebec post the 1st wave of CV19 in that region. Pts were asked if they planned taking the fluv and/or an eventual CVv, reasons for reticence to v, and attitudes toward and compliance with public health (PH) directives. They were also asked their primary source of health related information. Recent HbA1c and insulin use were recorded. Thirty four T2Ds were surveyed, 22 M 50–87 yrs (mean 69.2) and 12 F 49–84 yrs (mean 68.8). Eleven M and 5 F were on insulin. HbA1c ranged from 5.9–13.0 (mean 7.3). None of the pts had recently discussed v with a healthcare provider (HCP). One pt received his health related information from Facebook, the others from mainstream media. None had contraindications to v. None had been diagnosed with CV19. Past influenza history was unknown. Forty one percent (14/34) of pts, 11 M 50–86 yrs (mean 66.0) and 3 F 49–66 yrs (mean 59.0) did not plan to take the fluv. They explained their decisions as never having taken fluv (12 pts) or having been ill despite having taken it (2 pts). Neither accessibility nor cost were issues. Two F, 62 and 66 yrs, who refused fluv also refused CVv. Six M aged 60–86 yrs (mean 70.5) and 1 F aged 73 yrs were planning to wait to access real life safety (6pts) or efficacy (1pt) data before accepting CVv. All pts claimed to be following PH guidelines including social distancing, hand washing, and mask recommendations; 91.2% (31/34) fully agreed with PH policies, 2 were in moderate agreement and 1 thought PH policy was not strict enough. Of the latter 3 pts none planned on taking the fluv. One planned taking the CVv, 1 planned not to, and the 3rd planned to wait before deciding. Despite a long history of use, recommendations by experts, and free and easy accessibility, T2D pts questioned after the 1st wave of CV19 are not convinced of the fluv’s importance. Despite high case numbers and being themselves at high risk, not all T2Ds are willing to unequivocally accept a potential Health Canada sanctioned CVv. This study underlines the important work HCPs have ahead in educating and reassuring pts with regard to vaccination." @default.
- W3159523523 created "2021-05-10" @default.
- W3159523523 creator A5009873897 @default.
- W3159523523 creator A5028446169 @default.
- W3159523523 creator A5036619073 @default.
- W3159523523 date "2021-05-01" @default.
- W3159523523 modified "2023-09-24" @default.
- W3159523523 title "Type ll Diabetic Patients’ Attitudes Toward Influenza and Covid-19 Vaccination" @default.
- W3159523523 doi "https://doi.org/10.1210/jendso/bvab048.716" @default.
- W3159523523 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8090011" @default.
- W3159523523 hasPublicationYear "2021" @default.
- W3159523523 type Work @default.
- W3159523523 sameAs 3159523523 @default.
- W3159523523 citedByCount "0" @default.
- W3159523523 crossrefType "journal-article" @default.
- W3159523523 hasAuthorship W3159523523A5009873897 @default.
- W3159523523 hasAuthorship W3159523523A5028446169 @default.
- W3159523523 hasAuthorship W3159523523A5036619073 @default.
- W3159523523 hasBestOaLocation W31595235231 @default.
- W3159523523 hasConcept C126322002 @default.
- W3159523523 hasConcept C144024400 @default.
- W3159523523 hasConcept C149923435 @default.
- W3159523523 hasConcept C203014093 @default.
- W3159523523 hasConcept C22070199 @default.
- W3159523523 hasConcept C2779134260 @default.
- W3159523523 hasConcept C3008058167 @default.
- W3159523523 hasConcept C512399662 @default.
- W3159523523 hasConcept C524204448 @default.
- W3159523523 hasConcept C71924100 @default.
- W3159523523 hasConcept C89623803 @default.
- W3159523523 hasConceptScore W3159523523C126322002 @default.
- W3159523523 hasConceptScore W3159523523C144024400 @default.
- W3159523523 hasConceptScore W3159523523C149923435 @default.
- W3159523523 hasConceptScore W3159523523C203014093 @default.
- W3159523523 hasConceptScore W3159523523C22070199 @default.
- W3159523523 hasConceptScore W3159523523C2779134260 @default.
- W3159523523 hasConceptScore W3159523523C3008058167 @default.
- W3159523523 hasConceptScore W3159523523C512399662 @default.
- W3159523523 hasConceptScore W3159523523C524204448 @default.
- W3159523523 hasConceptScore W3159523523C71924100 @default.
- W3159523523 hasConceptScore W3159523523C89623803 @default.
- W3159523523 hasIssue "Supplement_1" @default.
- W3159523523 hasLocation W31595235231 @default.
- W3159523523 hasLocation W31595235232 @default.
- W3159523523 hasOpenAccess W3159523523 @default.
- W3159523523 hasPrimaryLocation W31595235231 @default.
- W3159523523 hasRelatedWork W3103289217 @default.
- W3159523523 hasRelatedWork W3106370311 @default.
- W3159523523 hasRelatedWork W3108360120 @default.
- W3159523523 hasRelatedWork W3119540162 @default.
- W3159523523 hasRelatedWork W3152606407 @default.
- W3159523523 hasRelatedWork W3152916563 @default.
- W3159523523 hasRelatedWork W4313474620 @default.
- W3159523523 hasRelatedWork W4327956415 @default.
- W3159523523 hasRelatedWork W4381432928 @default.
- W3159523523 hasRelatedWork W4381942459 @default.
- W3159523523 hasVolume "5" @default.
- W3159523523 isParatext "false" @default.
- W3159523523 isRetracted "false" @default.
- W3159523523 magId "3159523523" @default.
- W3159523523 workType "article" @default.